T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way ...

Researchers identified five factors that predict response to immunotherapy, advancing personalized cancer treatment. This ...

Our findings pave the way for safer and more effective cancer immunotherapies, potentially transforming the landscape of ...

A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with adv ...

Researchers at the NUS Yong Loo Lin School of Medicine, demonstrated that vesicles released by red blood cells can be ...

Since immunotherapy has been approved by the Food and Drug Administration to treat advanced head and neck cancer (HNC), it has offered patients new ...

Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to recognize and attack cancer cells more ...

13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer ...

We take a look at some of the findings that emerged at this year’s European Society for Medical Oncology conference. Some 30,000 people attend the forum to hear what advances doctors and researchers ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

What are the characteristics of a cancer cell that are recognized by the immune system? Knowledge of the potential target structures for the immune cells is a basic prerequisite for the ...

The NeoCOAST-2 trial was supported by AstraZeneca. Cascone disclosed relationships with AstraZeneca, Bristol Myers Squibb, Merck, Genentech, ONKo-innate, Pfizer, RAPT Therapeutics, Regeneron, Dava ...